| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Authors, Referees and Readers 2019
|
Sabbagh, Marwan
|
|
|
8 |
2 |
p. 513-515
|
artikel
|
| 2 |
Acknowledgement to Authors, Referees and Readers 2019
|
Sabbagh, Marwan
|
|
|
8 |
2 |
p. 513-515
|
artikel
|
| 3 |
Adapting the Goal Attainment Approach for Major Depressive Disorder
|
McCue, Maggie
|
|
|
8 |
2 |
p. 167-176
|
artikel
|
| 4 |
Adapting the Goal Attainment Approach for Major Depressive Disorder
|
McCue, Maggie
|
|
|
8 |
2 |
p. 167-176
|
artikel
|
| 5 |
A Novel Dual-Frequency Deep Brain Stimulation Paradigm for Parkinson’s Disease
|
Karl, Jessica A.
|
|
|
8 |
2 |
p. 483-489
|
artikel
|
| 6 |
A Novel Dual-Frequency Deep Brain Stimulation Paradigm for Parkinson’s Disease
|
Karl, Jessica A.
|
|
|
8 |
2 |
p. 483-489
|
artikel
|
| 7 |
Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
|
deVries, Tina
|
|
|
8 |
2 |
p. 449-460
|
artikel
|
| 8 |
Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies
|
deVries, Tina
|
|
|
8 |
2 |
p. 449-460
|
artikel
|
| 9 |
Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
|
Rivera, Victor M.
|
|
|
8 |
2 |
p. 177-184
|
artikel
|
| 10 |
Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
|
Rivera, Victor M.
|
|
|
8 |
2 |
p. 177-184
|
artikel
|
| 11 |
Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
|
Tahami Monfared, Amir Abbas
|
|
|
8 |
2 |
p. 289-305
|
artikel
|
| 12 |
Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
|
Tahami Monfared, Amir Abbas
|
|
|
8 |
2 |
p. 289-305
|
artikel
|
| 13 |
Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled Trial
|
Wongjirattikarn, Rachot
|
|
|
8 |
2 |
p. 425-431
|
artikel
|
| 14 |
Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled Trial
|
Wongjirattikarn, Rachot
|
|
|
8 |
2 |
p. 425-431
|
artikel
|
| 15 |
Case Report of a Novel Technique for Repairof the Vertebral Artery During Cranial Surgery
|
Prasad, Manjunath
|
|
|
8 |
2 |
p. 505-509
|
artikel
|
| 16 |
Case Report of a Novel Technique for Repair of the Vertebral Artery During Cranial Surgery
|
Prasad, Manjunath
|
|
|
8 |
2 |
p. 505-509
|
artikel
|
| 17 |
Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review
|
Walker, Lisa A. S.
|
|
|
8 |
2 |
p. 251-271
|
artikel
|
| 18 |
Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review
|
Walker, Lisa A. S.
|
|
|
8 |
2 |
p. 251-271
|
artikel
|
| 19 |
Correction to: Abstracts from the 5th International Porto Congress of Multiple Sclerosis
|
Sá, Maria José
|
|
|
8 |
2 |
p. 511
|
artikel
|
| 20 |
Correction to: Abstracts from the 5th International Porto Congress of Multiple Sclerosis
|
Sá, Maria José
|
|
|
8 |
2 |
p. 511
|
artikel
|
| 21 |
Deep Learning and Neurology: A Systematic Review
|
Valliani, Aly Al-Amyn
|
|
|
8 |
2 |
p. 351-365
|
artikel
|
| 22 |
Deep Learning and Neurology: A Systematic Review
|
Valliani, Aly Al-Amyn
|
|
|
8 |
2 |
p. 351-365
|
artikel
|
| 23 |
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease
|
Burke, Anna D.
|
|
|
8 |
2 |
p. 325-350
|
artikel
|
| 24 |
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease
|
Burke, Anna D.
|
|
|
8 |
2 |
p. 325-350
|
artikel
|
| 25 |
Diagnosing and Treating Depression in Patients with Alzheimer’s Disease
|
Burke, Anna D.
|
|
|
8 |
2 |
p. 325-350
|
artikel
|
| 26 |
Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study
|
Lawthom, Charlotte
|
|
|
8 |
2 |
p. 491-504
|
artikel
|
| 27 |
Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study
|
Lawthom, Charlotte
|
|
|
8 |
2 |
p. 491-504
|
artikel
|
| 28 |
Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and Syllable Repetition in Subjects with Aphasia: A Crossover, Double-Blinded, Sham-Controlled Trial
|
Vila-Nova, Camila
|
|
|
8 |
2 |
p. 411-424
|
artikel
|
| 29 |
Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and Syllable Repetition in Subjects with Aphasia: A Crossover, Double-Blinded, Sham-Controlled Trial
|
Vila-Nova, Camila
|
|
|
8 |
2 |
p. 411-424
|
artikel
|
| 30 |
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)
|
Okai, Annette F.
|
|
|
8 |
2 |
p. 367-381
|
artikel
|
| 31 |
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study)
|
Okai, Annette F.
|
|
|
8 |
2 |
p. 367-381
|
artikel
|
| 32 |
Fingolimod Immune Effects Beyond Its Sequestration Ability
|
Sica, Francesco
|
|
|
8 |
2 |
p. 231-240
|
artikel
|
| 33 |
Fingolimod Immune Effects Beyond Its Sequestration Ability
|
Sica, Francesco
|
|
|
8 |
2 |
p. 231-240
|
artikel
|
| 34 |
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations
|
Barry, Brian
|
|
|
8 |
2 |
p. 241-250
|
artikel
|
| 35 |
Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations
|
Barry, Brian
|
|
|
8 |
2 |
p. 241-250
|
artikel
|
| 36 |
Late Onset of Neuromyelitis Optica Spectrum Disorders
|
Fragoso, Yara Dadalti
|
|
|
8 |
2 |
p. 477-482
|
artikel
|
| 37 |
Late Onset of Neuromyelitis Optica Spectrum Disorders
|
Fragoso, Yara Dadalti
|
|
|
8 |
2 |
p. 477-482
|
artikel
|
| 38 |
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials
|
Ghezzi, Angelo
|
|
|
8 |
2 |
p. 461-475
|
artikel
|
| 39 |
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials
|
Ghezzi, Angelo
|
|
|
8 |
2 |
p. 461-475
|
artikel
|
| 40 |
Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients with Relapsing–Remitting Multiple Sclerosis: Pooled Analysis from the FREEDOMS/FREEDOMS II Trials
|
Ghezzi, Angelo
|
|
|
8 |
2 |
p. 461-475
|
artikel
|
| 41 |
Long-Term Observation of the Safety and Effectiveness of Enzyme Replacement Therapy in Japanese Patients with Pompe Disease: Results From the Post-marketing Surveillance
|
Nagura, Hitoshi
|
|
|
8 |
2 |
p. 397-409
|
artikel
|
| 42 |
Long-Term Observation of the Safety and Effectiveness of Enzyme Replacement Therapy in Japanese Patients with Pompe Disease: Results From the Post-marketing Surveillance
|
Nagura, Hitoshi
|
|
|
8 |
2 |
p. 397-409
|
artikel
|
| 43 |
Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital
|
Nakamura, Yusuke
|
|
|
8 |
2 |
p. 433-447
|
artikel
|
| 44 |
Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital
|
Nakamura, Yusuke
|
|
|
8 |
2 |
p. 433-447
|
artikel
|
| 45 |
Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer
|
Cutsforth-Gregory, Jeremy K.
|
|
|
8 |
2 |
p. 307-324
|
artikel
|
| 46 |
Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
|
Javed, Afzal
|
|
|
8 |
2 |
p. 215-230
|
artikel
|
| 47 |
Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia
|
Javed, Afzal
|
|
|
8 |
2 |
p. 215-230
|
artikel
|
| 48 |
Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
|
Steinberg, Judith
|
|
|
8 |
2 |
p. 207-214
|
artikel
|
| 49 |
Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
|
Steinberg, Judith
|
|
|
8 |
2 |
p. 207-214
|
artikel
|
| 50 |
Therapy of Sialorrhea with Botulinum Neurotoxin
|
Jost, Wolfgang H.
|
|
|
8 |
2 |
p. 273-288
|
artikel
|
| 51 |
Therapy of Sialorrhea with Botulinum Neurotoxin
|
Jost, Wolfgang H.
|
|
|
8 |
2 |
p. 273-288
|
artikel
|
| 52 |
Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population
|
Nazareth, Tara
|
|
|
8 |
2 |
p. 383-395
|
artikel
|
| 53 |
Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population
|
Nazareth, Tara
|
|
|
8 |
2 |
p. 383-395
|
artikel
|
| 54 |
Two Sides to Every Story: Perspectives from Four Patients and a Healthcare Professional on Multiple Sclerosis Disease Progression
|
Burtchell, Jeri
|
|
|
8 |
2 |
p. 185-205
|
artikel
|
| 55 |
Two Sides to Every Story: Perspectives from Four Patients and a Healthcare Professional on Multiple Sclerosis Disease Progression
|
Burtchell, Jeri
|
|
|
8 |
2 |
p. 185-205
|
artikel
|
Tijdschrift beschrijving